Efficacy and Safety of 1470-nm Diode Laser Enucleation of the Prostate in Individuals With Benign Prostatic Hyperplasia Continuously Administered Oral Anticoagulants or Antiplatelet Drugs
Authors:
Abstract
No abstract availableKeywords
Funding Information
- Shanghai Science and Technology Committee (16411972000)
- Shanghai Key Medical Specialty Program (ZK2019A03)
This publication has 21 references indexed in Scilit:
- A Randomized Trial Comparing Diode Laser Enucleation of the Prostate with Plasmakinetic Enucleation and Resection of the Prostate for the Treatment of Benign Prostatic HyperplasiaJournal of Endourology, 2013
- Holmium Laser Enucleation of the Prostate Versus Transurethral Resection of the Prostate: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsJournal of Endourology, 2013
- Bladder outlet procedures in the setting of anticoagulation therapyCurrent Opinion in Urology, 2013
- The application of 120-W high-performance system GreenLight laser vaporization of the prostate in high-risk patientsLasers in Medical Science, 2012
- 120‐W 2‐µm thulium:yttrium–aluminium–garnet vapoenucleation of the prostate: 12‐month follow‐upBJU International, 2011
- Critical review of lasers in benign prostatic hyperplasia (BPH)BJU International, 2011
- Impact of oral anticoagulation on morbidity of transurethral resection of the prostateWorld Journal of Urology, 2010
- Laser Treatment of Benign Prostatic Hyperplasia in Patients on Oral Anticoagulant TherapyCurrent Urology Reports, 2010
- Preliminary Results of Prostate Vaporization in the Treatment of Benign Prostatic Hyperplasia by Using a 200-W High-intensity Diode LaserUrology, 2010
- Prospective single‐centre comparison of 120‐W diode‐pumped solid‐state high‐intensity system laser vaporization of the prostate and 200‐W high‐intensive diode‐laser ablation of the prostate for treating benign prostatic hyperplasiaBJU International, 2009